The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
Purpose of this funding opportunity announcement is to encourage collaborations- between life science and physical science- that: 1) apply a multidisciplinary bioengineering approach to solve biomedical problems; and 2) develop, integrate, optimize, validate, translate or accelerate adoption of promising tools, methods and techniques: a) that fulfill an unmet need and address specific research or clinical problem in basic, translational, and/or clinical science and practice, b) capable of enhancing our understanding of health and disease, and/or c) improve practice of medicine. Applications may propose design-directed, developmental, discovery-driven, or hypothesis-driven research, and this FOA is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical or translational science.
Companion FOA: PAR-22-243, Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
- Letter of Intent: 30 days prior to application due date.
- R01 Deadlines: October 31, 2022, then standard dates: Feb. 5, Jun. 5, Oct. 5.
- AIDS Deadlines: Jan. 7, May 7, Sep. 7.
PAR-22-242 Expiration Date: September 08, 2025